FDA Approved: DEFERASIROX — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approves Ascend Laboratories' original application for the generic iron chelator deferasirox.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload Due to Blood Transfusions

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

ORIG AP for DEFERASIROX (DEFERASIROX)